2008

April
Acquisition of 90% share in Zhejiang Chiral Medicine Chemicals Company, China, specialized in API manufacturing and R&D.

January
Acquisition of a manufacturing site in Nerviano, Italy.

2007

February
Acquisition of an API manufacturer in India.

2006

December
Acquisition of a manufacturing plant in India.
Establishment of an API development centre in India.

November
Entry into the speciality generics market with acquisition of Abrika Pharmaceuticals in the US.

Purchase of majority stake in Russian ZiO Zdorovje, a leading Russian pharmaceutical manufacturer. 

March
Actavis enters the field of oncology - acquisition of Sindan in Romania.

2005

December
Acquisition of Alpharma's human generics business finalised, placing

Actavis among the top five generic pharmaceutical companies in the world.

September
Acquisition of Keri Pharma in Hungary

Conditional acquisition of Higia, Bulgaria's largest pharmaceutical distributor.

May
Actavis acquires US based pharmaceutical company Amide.

March
Acquisition of Pharma Avalanche in Czech Republic and Slovakia.

February
Acquisition of CRO company Lotus Laboratories in India.

Strategic collaboration with Indian pharmaceutical manufacturer Emcure.

2004

December
Acquisition of Polish sales and marketing company Biovena.

July
Actavis sold its 15% stake in Velefarm back to the company.

May
Actavis is the new name for the Pharmaco Group.

January
An agreement is concluded on the acquisition of Turkish pharmaceutical company Fako.

Pharmaco acquires sales and marketing offices in Norway and Finland.

2003

Pharmaco acquires a 86% share in Danish R&D company Colotech.

Pharmaco opens offices in the US and Sweden.

Pharmaco acquires 15% in Serbian pharmaceuticals distributor Velefarm.

2002

Pharmaco concludes the sale of 80% of its Icelandic interest to newly - established PharmaNor.

Pharmaco acquires a majority share in Delta, before the two firms merge to create one of the largest companies in Iceland. Previously, Delta had acquired pharmaceutical company Pharmamed in Malta, UNP in Denmark and merged with pharmaceutical producer Omega Farma in Iceland.

Pharmaco acquires Zdravlje, one of the largest pharmaceutical companies in Serbia.

2001

Delta, later merged into Pharmaco (now Actavis Group), acquires Pharmamed, in Malta.

2000

Balkanpharma and Pharmaco merge.

1999

A watershed in Pharmaco's history. The company starts to establish an international presence. Along with Amber International Invest, Pharmaco jointly acquires Bulgarian pharmaceuticals manufacturer Balkanpharma.

1992

Ties between Pharmaco and Delta are severed to preclude a conflict of interest. Delta strengthens its position in Iceland and, with its entry into the German market, begins exporting on a large scale.

1981

Pharmaco establishes Delta hf. to manufacture registered pharmaceutical products. Holds a two-third share in the company until 1992.

1972

Local legislation means exclusive agencies take responsibility for managing Icelandic pharmaceutical supplies. Pharmaco becomes the authorised agent for several well-known manufacturers, including Astra Zeneca and Aventis. Later legislation makes it possible for Icelandic drug manufacturers to register their products as proprietary medicines.

1960

Pharmaco begins production of its own pharmaceuticals, initially for the domestic market.

1956

Pharmaco founded as a purchasing alliance by seven Icelandic pharmacists.